Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy.
Journal: JCO oncology practice
Published: June 23, 2026
Correction: Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection.
Journal: Annals of surgical oncology
Published: April 24, 2026
Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus.
Journal: Cancers
Published: November 27, 2025
Investigating Chronic Toxicity, Diet, Patient-Reported Outcomes and the Microbiome in Immunotherapy-Treated Metastatic Melanoma Survivors: A New Frontier.
Journal: Nutrients
Published: October 31, 2025
Cellular neighborhoods govern antitumor T-cell infiltration following anti-CTLA-4 in melanoma with primary resistance to anti-PD-1.
Journal: Cancer discovery
Published: October 07, 2025
Germline variants in cancer susceptibility genes among patients with mucosal melanoma.
Journal: NPJ genomic medicine
Published: September 12, 2025
Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection.
Journal: Annals of surgical oncology
Published: August 01, 2025
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 12, 2025
Epigenetic Modulation, Intratumoral Microbiome, and Immunity in Early-Onset Colorectal Cancer.
Journal: Cancer research communications
Published: May 02, 2025
Epigenetic Modulation, Intra-tumoral Microbiome and Immunity in Early Onset Colorectal Cancer.
Journal: bioRxiv : the preprint server for biology
Published: April 16, 2025
Last Updated: 09/26/2026